Education
About Us
Working with TipRanks
Follow Us
Enfusion (ENFN)
NYSE:ENFN
ENFN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.83 - $11.80
Previous CloseN/A
Volume130.23K
Average Volume (3M)1.19M
Market Cap
$1.39B
Enterprise Value$1.22B
Total Cash (Recent Filing)$54.48M
Total Debt (Recent Filing)$20.31M
Price to Earnings (P/E)527.5
Beta0.60
Next Earnings
May 08, 2025EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding94,802,000
10 Day Avg. Volume1,558,031
30 Day Avg. Volume1,194,553
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.10
Price to Cash Flow (P/CF)37.00
P/FCF Ratio37.00
Enterprise Value/Market Cap0.88
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.95
Enterprise Value/Ebitda84.11
Forecast
1Y Price Target
$11.25Price Target Upside4.55% Upside
Rating ConsensusHold
Number of Analyst Covering1
---
Enfusion News
PremiumCompany Announcements
Enfusion Completes Merger with Clearwater, Delists from NYSE
PremiumCompany Announcements
Enfusion, Inc. Reports Strong Growth Amid Acquisition Plans
---
Bulls Say, Bears Say
Bulls Say
Acquisition PremiumThe acquisition by Clearwater Analytics values Enfusion at approximately $1.5 billion, with a ~50/50 split between cash and stock.
Strategic ValueSale to Clearwater unlocks untapped strategic value that would be challenging to extract in the public markets.
Bears Say
Revenue OutlookEnfusion announced that it is tracking towards or beyond the low-end of its previously announced outlook, which implicitly decreases the probability of near-term revenue reacceleration.
Stock DowngradeThe stock rating has been downgraded from Overweight to Equal-weight.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ENFN FAQ
What was Enfusion’s price range in the past 12 months?
Enfusion lowest stock price was $7.83 and its highest was $11.80 in the past 12 months.
What is Enfusion’s market cap?
Enfusion’s market cap is $1.39B.
When is Enfusion’s upcoming earnings report date?
Enfusion’s upcoming earnings report date is May 08, 2025 which is in 10 days.
How were Enfusion’s earnings last quarter?
Enfusion released its earnings results on Mar 03, 2025. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.063 by -$0.033.
Is Enfusion overvalued?
According to Wall Street analysts Enfusion’s price is currently Undervalued.
Does Enfusion pay dividends?
Enfusion does not currently pay dividends.
What is Enfusion’s EPS estimate?
Enfusion’s EPS estimate is 0.05.
How many shares outstanding does Enfusion have?
Enfusion has 94,802,000 shares outstanding.
What happened to Enfusion’s price movement after its last earnings report?
Enfusion reported an EPS of $0.03 in its last earnings report, missing expectations of $0.063. Following the earnings report the stock price went up 0.264%.
Which hedge fund is a major shareholder of Enfusion?
Currently, no hedge funds are holding shares in ENFN
---
Enfusion Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$11.25 (4.55% Upside)
$11.25 (4.55% Upside)
Blogger Sentiment
Bullish
ENFN Sentiment 100%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 65.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $543.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
―
20 days / 200 days
Momentum
16.57%
12-Months-Change
Fundamentals
Return on Equity
4.45%
Trailing 12-Months
Asset Growth
31.47%
Trailing 12-Months
Company Description
Enfusion
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
---
ENFN Stock 12 Month Forecast
Average Price Target
$11.25
▲(4.55% Upside)
Technical Analysis
Best Analysts Covering ENFN
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-7.42%
reiterated a sell rating 12 months ago
Copying Koji Ikeda's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -7.42% per trade.
---